Status:
UNKNOWN
Implantation of Allogenic Mesenchymal Stem Cell From Umbilical Cord Blood for Osteoarthritis Management
Lead Sponsor:
Indonesia University
Conditions:
Osteoarthritis, Knee
Eligibility:
All Genders
30-80 years
Phase:
EARLY_PHASE1
Brief Summary
Prevalence of osteoarthritis increases every year, as a chronic and progressive disease. Osteoarthritis also gives many negative impacts in socio-economic life. Current management of osteoarthritis on...
Detailed Description
This study is experimental clinical, randomized control trial. This study estimated time would be 24 months, from May 2016 until May 2018. Samples are obtained consecutively from all source population...
Eligibility Criteria
Inclusion
- Patients aged 30-80 years old
- Kellgren-Lawrence grade I, II, and III, or KL grade III with corrective osteotomy according to knee x-ray examination
- Minimal VAS: 2
- Unresponsive with pharmacological therapy
- Signed the informed consent
Exclusion
- Osteoarthritis KL grade IV
- Secondary osteoarthritis due to trauma, infection, rheumatoid arthritis, congenital diseases, autoimmune diseases
- Hypersensitivity to hyaluronic acid
- Malignancies (Previously or currently diagnosed)
- Pregnancy
Key Trial Info
Start Date :
May 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2019
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT03800810
Start Date
May 1 2015
End Date
May 1 2019
Last Update
January 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitas Indonesia
Jakarta Pusat, Jakarta Special Capital Region, Indonesia, 10430